IPHA
Innate Pharma
IPHA
IPHA
9 hedge funds and large institutions have $731K invested in Innate Pharma in 2024 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 3 increasing their positions, 2 reducing their positions, and closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
9
Holders Change
+1
Holders Change %
+12.5%
% of All Funds
0.13%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
3
Reduced
2
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
ETC
Exchange Traded Concepts
Oklahoma City,
Oklahoma
|
+$191K |
| 2 |
Optiver Holding
Amsterdam,
Netherlands
|
+$138K |
| 3 |
Jane Street
New York
|
+$41.9K |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$184 |
Top Sellers
| 1 |
Morgan Stanley
New York
|
-$140K |
| 2 |
Millennium Management
New York
|
-$4.1K |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
ETC
1
Exchange Traded Concepts
Oklahoma City,
Oklahoma
| $326K | +$191K | +66,182 | +141% |
|
|
2
Optiver Holding
Amsterdam,
Netherlands
| $203K | +$138K | +47,859 | +211% |
|
|
3
Morgan Stanley
New York
| $127K | -$140K | -48,584 | -52% |
|
|
4
Jane Street
New York
| $41.9K | +$41.9K | +14,554 | New |
|
|
5
Millennium Management
New York
| $30.5K | -$4.1K | -1,423 | -12% |
|
6
Barclays
London,
United Kingdom
| $1K | – | – | – |
|
|
7
UBS Group
Zurich,
Switzerland
| $604 | +$184 | +64 | +44% |
|
8
RhumbLine Advisers
Boston,
Massachusetts
| $590 | – | – | – |
|
|
SPIA
9
Steward Partners Investment Advisory
New York
| $576 | – | – | – |
|